Drug Profile
Traxanox
Alternative Names: Traxanox sodium; Traxanox sodium pentahydrate; Y 12141; YZ 12141Latest Information Update: 28 Nov 1997
Price :
$50
*
At a glance
- Originator Mitsubishi Pharma Corporation
- Class Antiallergics; Antiasthmatics; Antibronchitics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 28 Nov 1997 No-Development-Reported for Allergic rhinitis in Japan (Unknown route)
- 28 Nov 1997 No-Development-Reported for Asthma in Japan (Unknown route)
- 23 Feb 1995 Investigation in Allergic rhinitis in Japan (Unknown route)